| Literature DB >> 34337027 |
Haidi Lu1, Yuan Yuan1, Zhen Zhou1, Xiaolu Ma1, Fu Shen1, Yuwei Xia2, Jianping Lu1.
Abstract
The manual delineation of the lesion is mainly used as a conventional segmentation method, but it is subjective and has poor stability and repeatability. The purpose of this study is to validate the effect of a radiomics model based on MRI derived from two delineation methods in the preoperative T staging of patients with rectal cancer (RC). A total of 454 consecutive patients with pathologically confirmed RC who underwent preoperative MRI between January 2018 and December 2019 were retrospectively analyzed. RC patients were grouped according to whether the muscularis propria was penetrated. Two radiologists segmented lesions, respectively, by minimum delineation (Method 1) and maximum delineation (Method 2), after which radiomics features were extracted. Inter- and intraclass correlation coefficient (ICC) of all features was evaluated. After feature reduction, the support vector machine (SVM) was trained to build a prediction model. The diagnostic performances of models were determined by receiver operating characteristic (ROC) curves. Then, the areas under the curve (AUCs) were compared by the DeLong test. Decision curve analysis (DCA) was performed to evaluate clinical benefit. Finally, 317 patients were assessed, including 152 cases in the training set and 165 cases in the validation set. Moreover, 1288/1409 (91.4%) features of Method 1 and 1273/1409 (90.3%) features of Method 2 had good robustness (P < 0.05). The AUCs of Model 1 and Model 2 were 0.808 and 0.903 in the validation set, respectively (P = 0.035). DCA showed that the maximum delineation yielded more net benefit. MRI-based radiomics models derived from two segmentation methods demonstrated good performance in the preoperative T staging of RC. The minimum delineation had better stability in feature selection, while the maximum delineation method was more clinically beneficial.Entities:
Year: 2021 PMID: 34337027 PMCID: PMC8289571 DOI: 10.1155/2021/5566885
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Diagram for the inclusion of patients into the study. RC: rectal cancer.
Figure 2Representative images for lesion delineation. (a, b) Minimum delineation of ROI on oblique-axial T2-weighted MR images (arrow) and volume renderings of VOIs (Method 1). (c, d) Maximum delineation of ROI on oblique-axial T2-weighted MR images (arrow) and volume renderings of VOIs (Method 2).
Pathological characteristics of the patients.
| Variables | Training set | Validation set |
| |
|---|---|---|---|---|
| ( | ( | |||
| Gender | Male | 94 (61.8%) | 109 (66.1%) | 0.434 |
| Female | 58 (38.2%) | 56 (33.9%) | ||
| Age (years) | 58.9 ± 8.3 | 57.5 ± 8.8 | 0.147 | |
| BMI (kg/m2) | 23.8 ± 3.2 | 23.5 ± 3.1 | 0.397 | |
| Tumor location | Upper | 36 (23.7%) | 32 (19.4%) | 0.648 |
| Middle | 92 (60.5%) | 105 (63.6%) | ||
| Lower | 24 (15.8%) | 28 (17.0%) | ||
| Histological type | Adenocarcinoma | 131 (86.2%) | 146 (88.5%) | 0.325 |
| Mucinous adenocarcinoma | 15 (9.9%) | 17 (10.3%) | ||
| Signet ring cell carcinoma | 6 (3.9%) | 2 (1.2%) | ||
| Differentiation | High | 20 (13.2%) | 17 (10.3%) | 0.713 |
| Moderate | 112 (73.7%) | 127 (77.0%) | ||
| Poor | 20 (13.2%) | 21 (12.7%) | ||
| T stage | T1 | 22 (14.5%) | 17 (10.3%) | 0.320 |
| T2 | 44 (28.9%) | 51 (30.9%) | ||
| T3 | 74 (48.7%) | 90 (54.5%) | ||
| T4 | 12 (7.9%) | 7 (4.2%) | ||
| N stage | N0 | 94 (61.8%) | 99 (60.0%) | 0.056 |
| N1 | 37 (24.3%) | 28 (17.0%) | ||
| N2 | 21 (13.8%) | 38 (23.0%) | ||
| Tumor deposit | Negative | 118 (77.6%) | 137 (83.0%) | 0.226 |
| Positive | 34 (22.4%) | 28 (17.0%) | ||
| Lymphovascular invasion | Negative | 91 (59.9%) | 100 (60.6%) | 0.893 |
| Positive | 61 (40.1%) | 65 (39.4%) | ||
| Perineural invasion | Negative | 106 (69.7%) | 117 (70.9%) | 0.819 |
| Positive | 46 (30.3%) | 48 (29.1%) | ||
| Tumor budding | Negative | 114 (75.0%) | 126 (76.4%) | 0.777 |
| Positive | 38 (25.0%) | 39 (23.6%) | ||
| CEA∗ | Negative | 107 (70.4%) | 115 (69.7%) | 0.892 |
| Positive | 45 (29.6%) | 50 (30.3%) | ||
| CA19-9∗ | Negative | 126 (82.9%) | 126 (76.4%) | 0.150 |
| Positive | 26 (17.1%) | 39 (23.6%) |
BMI: body mass index; CEA: carcinoembryonic antigen; CA19-9: carbohydrate antigen 19-9. ∗Preoperative blood samples.
Selected radiomics features.
| Model | No | Radiomics feature | Radiomics class | Filter |
|---|---|---|---|---|
| Method 1 | 1 | Skewness | First order | Wavelet-HLL∗ |
| 2 | Maximum | First order | Wavelet-HLL∗ | |
| 3 | High gray level zone emphasis | GLSZM | Wavelet-HLH∗ | |
| 4 | Gray level nonuniformity | GLSZM | Wavelet-LHL∗ | |
| Method 2 | 1 | Skewness | First order | Wavelet-HLL∗ |
| 2 | High gray level zone emphasis | GLSZM | Wavelet-LHL∗ | |
| 3 | Skewness | First order | Wavelet-LHL∗ | |
| 4 | High gray level run emphasis | GLRLM | Original | |
| 5 | High gray level run emphasis | GLRLM | Logarithm | |
| 6 | High gray level run emphasis | GLRLM | Square root | |
| 7 | High gray level run emphasis | GLRLM | Wavelet-LLL∗ |
GLSZM: gray level size zone matrix; GLRLM: gray level run length matrix. ∗The wavelet transform decomposes the tumor area image into low-frequency components (L) or high-frequency components (H) in the x, y, and z axes. Method 1: minimum delineation method; Method 2: maximum delineation method.
Figure 3Receiver operator characteristic (ROC) curves in the validation set. AUC was 0.808 for the minimum delineation model (Method 1); AUC was 0.903 for the maximum delineation model (Method 2).
ROC analysis of the prediction model for the training and validation sets.
| Training set | Validation set | |||
|---|---|---|---|---|
| Method 1 | Method 2 | Method 1 | Method 2 | |
| AUC | 0.838 | 0.928 | 0.808 | 0.903 |
| 95% CI | 0.764-0.912 | 0.864-0.992 | 0.669-0.947 | 0.807-0.999 |
| Sensitivity | 0.871 | 0.903 | 0.956 | 0.870 |
| Specificity | 0.805 | 0.866 | 0.588 | 0.823 |
| Accuracy | 0.823 | 0.876 | 0.800 | 0.850 |
| PLR | 4.464 | 6.733 | 2.323 | 4.927 |
| NLR | 0.160 | 0.112 | 0.074 | 0.158 |
| PPV | 0.628 | 0.718 | 0.759 | 0.870 |
| NPV | 0.943 | 0.960 | 0.909 | 0.823 |
|
| 0.036 | 0.035 | ||
PLR: positive likelihood ratio; NLR: negative likelihood ratio; NPV: negative predictive value; PPV: positive predictive value. ∗Compared by DeLong test.
Figure 4Decision curve analysis (DCA) of the two schemes of delineation. DCA showed that at the probability threshold of 0.0 to 0.9, the SVM model based on the maximum algorithm provided more net benefit than utilizing the minimum delineation scheme. Model 1: minimum delineation method; Model 2: maximum delineation method.